Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Helen Parfitt
  • June 2, 2017
  • News

Therapy Watch expands oncology and IBD portfolios

This month Therapy Watch expands its portfolio with the launch of several new trackers across numerous therapy areas including the launch of a new Chronic Myelogenous Leukaemia (CML) study in the US.

This month Therapy Watch expands its portfolio with the launch of several new trackers across numerous therapy areas including the launch of a new Chronic Myelogenous Leukaemia (CML) study in the US. CML is a rare cancer affecting the white blood cells and accounts for only 20% of all leukaemias affecting adults. The new CML study will include a panel of Haematologists and Haemato-Oncologists reporting on CML patients every month, including both first-line and later-line patients, resulting in over 2000 patient record forms (PRFs). 

read more »

  • Posted by Julie Denny
  • April 26, 2017
  • News

Helen Parfitt joins as Director, Head of Therapy Watch

Helen Parfitt joins as Director, Head of Therapy Watch

Helen Parfitt has joined Research Partnership as Head of Therapy Watch at the company’s global head office in London.

Helen has over 20 years’ experience in the pharmaceutical industry and joins us from the M3 Group where she was a Commercial Director for their European division. Prior to this she was Director of Core Data Assets, Global Technology Services & Operations at IMS Health, where she led the global syndicated data portfolio. 

read more »